Metabolic Response as Assessed by 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Does Not Predict Outcome in Patients with Intermediate- or High-Risk Rhabdomyosarcoma: A Report from the Children's Oncology Group Soft Tissue Sarcoma Committee

ECU Author/Contributor (non-ECU co-authors, if there are any, appear on document): Yueh-Yun Chi (Creator); Douglas J. Harrison (Creator); Douglas S. Hawkins (Creator); Andrea A. Hayes-Jordan (Creator); Pooja Hingorani (Creator); Leo Mascarenhas (Creator); Geoffrey B. McCowage (Creator); William H. Meyer (Creator); Marguerite T. Parisi (Creator); David A. Rodeberg (Creator); Barry L. Shulki (Creator); Sheri L. Spunt (Creator); Lisa A. Teot (Creator); Jing Tian (Creator); Rajkumar Venkatramani (Creator); Brenda J. Weigel (Creator); Suzanne L. Wolden (Creator); Torunn I. Yock (Creator)
Institution: East Carolina University (ECU ); Web Site: http://www.ecu.edu/lib/

Additional Information

Publication: Other; Language: English; Date: 2023
Subjects: chemotherapy;maximum standard uptake value (SUVmax);rhabdomyosarcoma

Email this document to

This item references:

Title	Location & Link	Type of Relationship
Metabolic Response as Assessed by 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Does Not Predict Outcome in Patients with Intermediate- or High-Risk Rhabdomyosarcoma: A Report from the Children's Oncology Group Soft Tissue Sarcoma Committee	http://hdl.handle.net/10342/10731	The described resource references, cites, or otherwise points to the related resource.